Dagliflozin tablets are rarely used and there is no relevant basis, the drug belongs to a new type of hypoglycemic drugs, mainly in the epithelial cells of the renal tubules, can inhibit glucose absorption, a large amount of sugar can be discharged from the urine, so as to play a role in lowering glucose for the treatment of type 2 diabetes mellitus has a good effect, but is not suitable for use in type 1 diabetes mellitus.
However, Dagliflozin tablets have certain side effects, such as easy to urinary tract infection, which is due to the mechanism of action of Dagliflozin tablets.
After taking Dagliflozin tablets, a large amount of sugar is excreted from the urine, and high sugar can easily lead to the survival of all kinds of microorganisms, so it is easy to have urinary tract infections, and it is important to pay attention to the occurrence of side effects in the process of using.
The glucose-lowering mechanism of Dagliflozin is to inhibit the reabsorption of glucose in the renal tubules so as to achieve the effect of lowering blood glucose, so it is prone to cause low blood pressure, ketoacidosis, acute renal failure, renal function damage and so on.
When pyelonephritis, nephritis, uremia occurs, the use of dagliflozin should pay attention to check the renal function, if the renal function is not good, it is not recommended to use dagliflozin, and some other glucose-lowering drugs can be used.
In addition, Dagliflozin tablets should not be used in some special cases, such as patients who develop diabetic ketoacidosis and patients with low blood pressure, hypoglycemia and severe renal failure.
It is contraindicated for those who are allergic to the drug and its components, as well as for dialysis patients. Specific use must be carried out under the supervision of a doctor.